GREAT POINT PARTNERS LLC

4 followers ·
13F Summary

Subscription Required

Equal-WT
WhaleScore 2.0 ?

85

S&P 500
WhaleScore ?

Subscription Required

Equal-WT
WhaleScore 1.0 ?

Great Point Partners is based out of Greenwich. Great Point Partners is a hedge fund with 18 clients and discretionary assets under management (AUM) of $1,459,223,157 (Form ADV from 2025-03-28). Their last reported 13F filing for Q3 2025 included $242,495,757 in managed 13F securities and a top 10 holdings concentration of 63.25%. Great Point Partners's largest holding is Amylyx Pharmaceuticals Inc with shares held of 1,700,000. Whalewisdom has at least 59 13F filings, 31 13D filings, 429 13G filings, and 33 Form 4 filings
Business Description
Great Point consults an Advisory Board of limited partners of Clients for certain consents and approvals. Decisions of the Advisory Board are generally binding, but members owe no fiduciary duty to the Client and may act in the best interests of their affiliated investor. Although Great Point manages conflicts among Clients, Advisory Board members could have conflicts of interest that don't disqualify them from voting. Great Point also provides investment advisory services to Public Equity Clients, who operate in the same industry as Private Equity Funds, potentially creating conflicts. Great Point believes this is mitigated by investing in different sub-sectors and dedicating personnel to the Private Equity Funds.
Investment Strategy
Each Hedge Fund aims for positive excess returns by investing in publicly traded biotechnology, pharmaceutical, and life science companies. Great Point believes a balanced portfolio of undervalued companies can yield above-average returns. The Hedge Funds use a bottom-up, research-driven approach, investing in undervalued health care companies' securities. Securities are bought and sold in the open market and acquired through DNIs, often initiated by Great Point. Small and mid-cap stocks are the primary focus of the Hedge Funds' long exposure. Great Point may also modify or depart from its initial investment strategy.
Owners
  • THE JAY FAMILY SPRAY TRUST - ASSOCIATED NON-MANAGING MEMBER
  • JAY, JEFFREY, ROBERT - ELECTED MANAGER, MEMBER AND MANAGING DIRECTOR
  • PANZIER, RONALD, MARC - CHIEF OPERATING OFFICER AND CHIEF FINANCIAL OFFICER
  • Felsenthal, Adam, Brian - GENERAL COUNSEL AND CHIEF COMPLIANCE OFFICER
  • Click on the Ownership/Private Fund Data tab for more details.
Known Email Addresses
(Subscription Required)
Other Contact Information
(Subscription Required)